SCHEMBL19909043

SCHEMBL19909043

N#Cc1ccc2c(c1)c1cc(C#N)ccc1n2-c1cc(C#N)c(-c2ccncc2)cc1-n1c2ccc(C#N)cc2c2cc(C#N)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.39
PKN2 Q16513 1/20 0.39
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
CYP19A1 P11511 1/20 0.37
LRRK2 Q5S007 3/20 0.37
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE5A O76074 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
PTGS1 P23219 1/20 0.36
PDE4A P27815 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913203 0.94 CYP19A1 (0.38) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL19919622 0.92 STS (0.39) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL19908990 0.91 MAPK14 (0.39) PKN1PKN2CYP11B1CYP11B2LRRK2
SCHEMBL19909087 0.91 PKN1 (0.39) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL20923582 0.90 CYP11B1 (0.41) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL20923537 0.90 PDE3B (0.39) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL19909045 0.90 PKN1 (0.39) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL20923538 0.89 CYP19A1 (0.41) CYP11B1CYP11B2CYP19A1PDE3BPDE3A
SCHEMBL20923580 0.89 CYP19A1 (0.41) PKN1PKN2CYP11B1CYP11B2CYP19A1
SCHEMBL19909029 0.88 AURKA (0.39) CYP11B1CYP11B2HPGDMAPK14CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 PKN1 2614/4885PKN2 1926/4885CYP11B1 610/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 PKN1 1154/4885PKN2 741/4885CYP11B1 1400/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 PKN1 2614/4885PKN2 1926/4885CYP11B1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.